DIALYSIS · CCN 212543

DaVita Bertha Sirk Dialysis Center

BALTIMORE, MD 21212

DialysisProfitDaVita
$3.1M
TOTAL REVENUE
28.2%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.1M
Total costs
$2.2M
Operating income (rev − costs)
$865K
Operating margin
28.2%
Total charges
$3.2M
Total treatments
6,976
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5755—
Fistula Rate
DFC_FISTULA_RATE
44.371—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
148.248—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.39——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2371—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.9255—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
19.657—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
11.637—
Standardized ED Visits Ratio
DFC_SEDR
1.2127—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
17.920—